The symbol “**” indicates highly significant IL-10 and IL-17 differences between vitiligo patients and controls (P < 0.01)
Declarations
Acknowledgments
The author would like to express her sincere gratitude to the Deanship of the College of Applied Science at the University of Fallujah for their support of this project. Their guidance and resources were instrumental in the successful completion of this research. Additionally, the author extends her appreciation to colleagues and peers who provided valuable insights and feedback throughout the study.
Author contributions
HMS: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. The author read and approved the submitted version.
Conflicts of interest
The author declares that she has no conflicts of interest.
Ethical approval
According to our hospital policy, particularly at the Hospital for Dermatology Diseases, ethical committee approval is not required for case reports in this manuscript as long as written informed consent is obtained from the patients.
Consent to participate
Informed consent to participate in the study was obtained from all participants, or their parents or legal guardians of the participants.
Consent to publication
Not applicable.
Availability of data and materials
The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Wang X, Fan J, He K, Chen J, Li S. Serum cytokine profiles predict response to systemic glucocorticoid in active vitiligo.Postepy Derm Alergol. 2024;41:189–96. [DOI] [PubMed] [PMC]
Ismail IB, Bhat YJ, Islam MSU. Treatment Advances in Vitiligo: An Updated Review.Dermatol Pract Concept. 2025;15:4600. [DOI] [PubMed] [PMC]
Custurone P, Di Bartolomeo L, Irrera N, Borgia F, Altavilla D, Bitto A, et al. Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.Int J Mol Sci. 2021;22:11429. [DOI] [PubMed] [PMC]
Yang Y, Du Y, Cui B. Polyphenols targeting multiple molecular targets and pathways for the treatment of vitiligo.Front Immunol. 2024;15:1387329. [DOI] [PubMed] [PMC]
Shradha K, Gaikwad S. A comprehensive overview of vitiligo.Int J Sci R Tech. 2025;2:544–55. [DOI]
Beyzaee AM, Goldust M, Patil A, Rokni GR, Beyzaee S. The role of cytokines and vitamin D in vitiligo pathogenesis.J Cosmet Dermatol. 2022;21:6314–25. [DOI] [PubMed]
Kądziela M, Kutwin M, Karp P, Woźniacka A. Role of cytokines and chemokines in vitiligo and their therapeutic implications.J Clin Med. 2024;13:4919. [DOI] [PubMed] [PMC]
Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy.Nat Rev Clin Oncol. 2022;19:237–53. [DOI] [PubMed]
Marchioro HZ, Silva de Castro CC, Fava VM, Sakiyama PH, Dellatorre G, Miot HA. Update on the pathogenesis of vitiligo.An Bras Dermatol. 2022;97:478–90. [DOI] [PubMed] [PMC]
Xerfan EMS, Andersen ML, Tufik S, Facina AS, Tomimori J. The impact on the quality of life and sleep complaints in a vitiligo sample and the influence of inflammatory cytokines in the interaction between vitiligo and sleep.Cytokine. 2024;176:156493. [DOI] [PubMed]
Liu C, Liu X, Xin H, Li X. A Mendelian randomization study on the causal effects of circulating cytokines on the risk of vitiligo.Front Med (Lausanne). 2024;11:1375339. [DOI] [PubMed] [PMC]
Hlača N, Žagar T, Kaštelan M, Brajac I, Prpić-Massari L. Current concepts of vitiligo immunopathogenesis.Biomedicines. 2022;10:1639. [DOI] [PubMed] [PMC]
Abdulkhaliq RJ, Mohammed S, Abbas AAH. The role of some cytokines inwomen withRecurrent Abortion in Iraqi Women.Pak J Med Health Sci. 2017;11:496–502.
Gomes IA, de Carvalho FO, de Menezes AF, Almeida FM, Shanmugam S, de Souza Siqueira Quintans J, et al. The role of interleukins in vitiligo: a systematic review.J Eur Acad Dermatol Venereol. 2018;32:2097–111. [DOI] [PubMed]
Hamad AA, Mustafa HM, Mohsein OA. Detection of the levels of immune cytokines (IL4, IL5, TNF-α) in school-age and preschoolers with an Ascaris lumbricoides infection.J Parasit Dis. 2024;48:782–7. [DOI] [PubMed] [PMC]
Picone V, Coronella L, Scalvenzi M, Patruno C, Lizzi L, Cimmino M, et al. Potential future biologic therapies for the treatment of vitiligo: focus on phase 2 and 3.Expert Rev Clin Immunol. 2025;21:711–21. [DOI] [PubMed]
Chen Y, Zhan JY, Gao S. Li YR, Wu YF. Research progress of microbiome and pathogenesis of vitiligo.Life Res. 2021;4:13. [DOI]
Matarrese P, Puglisi R, Mattia G, Samela T, Abeni D, Malorni W. An overview of the biological complexity of vitiligo.Oxid Med Cell Longev. 2024;2024:3193670. [DOI] [PubMed] [PMC]
Saleh RO, Mahmood LA, Mohammed MA, Al-Rawi KF, Al-Hakeim HK. Use of some bone-related cytokines as predictors for rheumatoid arthritis severity by neural network analysis.Russ J Infect Immun. 2023;13:147–55. [DOI]
Yasmin TM, Aya BY, Amal H, Amira KA, Ahmed GS. Serum interleukin-22 and C-reactive protein in patients with vitiligo: A case-control study on 35 Egyptian patients.Egypt J Dermatol Venerol. 2021;41:32–37. [DOI]
Liang X, Guo F, Fan Q, Cai X, Wang J, Chen J, et al. Healthy lifestyle choices: new insights into vitiligo management.Front Immunol. 2024;15:1440705. [DOI] [PubMed] [PMC]
Faraj S, Kemp EH, Gawkrodger DJ. Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.Clin Exp Immunol. 2022;207:27–43. [DOI] [PubMed] [PMC]
